Editor of Patient Care Online.
Daily Dose: Finerenone Reduces CKD-associated CV Risk in Patients with T2D
Your daily dose of clinical news you may have missed.
Finerenone Reduces CKD-associated Composite Cardiovascular Risk in a New Subanalysis of FIDELITY Trial
Finerenone was associated with a decrease in composite CV risk in patients with CKD, T2D, eGFR of ≥25, and moderately to severely increased albuminuria.
Daily Dose: Flash CGM Improves Glycemic Control in Patients with T2D Using Noninsulin Therapies
Daily Dose: Metformin Reduces Risk of Long COVID
Diabetes, Prediabetes, and Diabetes Duration Linked to Higher Risk of COPD, Death
Patients with diabetes had a 35% higher risk of COPD compared with those without diabetes, according to new research.
Metformin Reduced Long COVID Risk by About 40% vs Placebo in a New Phase 3 Trial
More research is needed to determine whether metformin is also effective in patients with lower body mass index or with previous infection, said researchers.
Daily Dose: RSV LRTI in Infancy Linked to More Clinical, Pulmonary Function Sequelae
Cost-related Medication Non-adherence Among US Adults: Unveiling Insights from NCHS Data Brief
A new data brief from the NCHS examined the characteristics of US adults who did not take medication as prescribed to reduce costs. A breakdown of the results, here.
STUDY: Infants Hospitalized for RSV with LRTI Face Increased Symptoms and Lung Function Abnormalities by Age 2
Children hospitalized for RSV with LRTI during infancy have increased symptoms and lung function abnormalities, including increased resistance and decreased compliance.
GSK Adult RSV Vaccine: 3 Things Primary Care Clinicians Should Remember
Medical director of the NFID William Schaffner, MD, shares 3 things about the RSV vaccine that should be top of mind for primary care clinicians.
Daily Dose: Prediabetes, Intervening Diabetes, & Subsequent Dementia Risk
Younger Age at Diabetes Onset Associated with Higher Risk of Dementia, According to New Study
Results also showed that prediabetes is associated with dementia risk but this risk was explained by the subsequent development of diabetes.
Daily Dose: Adherence to GLP1RA, SGLT2i Therapies & Prescription Copayment Level
Lower Adherence with GLP1RA, SGLT2i Therapies Linked to Higher Prescription Copayments
In a new study of adults with T2D and/or HF, those with higher prescription copayments were less likely to achieve 1-year adherence to GLP1-RA and SGLT2i therapies.
Diabetes Associated with Higher Risk of Death in Persons Hospitalized with Acute Myocardial Infarction
After an acute myocardial infarction, adults with diabetes were over 50% more likely to die after 1 year than those without diabetes, a new study shows.
Daily Dose: Subclinical CVD Affects 1 in 3 US Adults with Diabetes
Landmark NIH Study: Symptom-based Scoring System May Help Diagnose Long COVID
Researchers found a total of 12 symptoms that contributed to the long COVID scoring system.
Adult RSV Vaccine: How Will Older Adults React to New Kid on the Block?
Delivering 3 vaccines to older adults is going to be a challenge this fall, says Dr William Schaffner.
Daily Dose: Disparities in Diabetes Care
FDA Approves First Oral Antiviral Medication for COVID-19 Treatment among Adults
The FDA approved Paxlovid™ for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe disease.
Daily Dose: Weight Management in Primary Care
Daily Dose: FDA Approves Buprenorphine Extended-release Injection for Opioid Use Disorder
Not Enough Primary Care Clinicians Address Obesity with Patients, According to New Research
Findings highlight the need to develop strategies to improve weight management in primary care, according to study authors.
FDA Approves Buprenorphine Extended-release Injection for Moderate-to-Severe Opioid Use Disorder
Brixadi is the first and only long-acting buprenorphine injectable that is available in both weekly and monthly doses.
Daily Dose: Migraine without Aura Raises Stroke Risk for Women on Combined Hormonal Contraceptives
GSK Adult RSV Vaccine: Expert Highlights Path to FDA Approval
Medical director of the NFID William Schaffner, MD, discusses the research behind the FDA's decision to approve the first-ever RSV vaccine.
Daily Dose: Global Deaths from Ischemic Stroke May Reach 5 Million by 2030
Mental Health in Women with Obesity: An Expert Interview
A nationally recognized obesity expert discusses mental health in women with obesity.
Daily Dose: Rise in Diabetes-Related Vascular Deaths Linked to Renal Complications
Global Deaths from Ischemic Stroke May Reach 5 Million by 2030, According to New Study
Findings also showed that between 1990 and 2019, the global number of ischemic stroke deaths rose from 2 million to 3 million.